Tesamorelin Reconstitution and Dosing Calculation
When you add 3 mL of bacteriostatic water to a 10 mg vial of tesamorelin, the resulting concentration is 3.33 mg/mL, and you would draw 0.6 mL to achieve the standard 2 mg dose.
Concentration After Reconstitution
- Adding 3 mL of bacteriostatic water to a 10 mg vial creates a final concentration of 10 mg ÷ 3 mL = 3.33 mg/mL 1, 2, 3
Standard Dosing Volume
- The FDA-approved dose of tesamorelin is 2 mg administered subcutaneously once daily 1, 2, 3, 4
- To obtain 2 mg from a 3.33 mg/mL solution: 2 mg ÷ 3.33 mg/mL = 0.6 mL 1, 4
Reconstitution Technique
- Use sterile technique when reconstituting the medication, similar to principles outlined for other injectable preparations 5
- The reconstituted solution should be inspected visually for particulate matter and discoloration before administration 5
- Refrigerate the reconstituted vial and use within the manufacturer's specified timeframe 5
Clinical Context
- Tesamorelin has been studied extensively at the 2 mg daily dose in HIV-infected patients with abdominal fat accumulation, showing significant reductions in visceral adipose tissue (approximately -27.71 cm² compared to placebo) 6, 1
- The medication is administered subcutaneously and has been well-tolerated in clinical trials, including in patients on integrase inhibitor-based antiretroviral regimens 7, 4
- Effects on visceral fat are sustained during continuous treatment but reverse upon discontinuation 8, 4
Important Safety Considerations
- Monitor glucose parameters, particularly during the first 2 weeks of therapy, as transient increases in fasting glucose have been observed 1
- Common injection-site reactions include erythema, and systemic effects may include arthralgia, myalgia, and peripheral edema 2, 3, 6
- The medication should not be used in patients with active malignancy or disruption of the hypothalamic-pituitary axis 2, 3